Patients with COVID‐19 disease are prone to develop significant weight loss and clinical
cachexia. Three reports with altogether 589 patients that reported on weight loss and …

Introduction The COVID-19 outbreak has put enormous pressure on the scientific community
to detect infection rapidly, identify the status of disease severity, and provide an immediate …

Purpose of review: Although the respiratory system is the main target of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), it is evident from recent data that other …

COVID-19 is associated with significant extrapulmonary symptoms. Myocardial involvement
has been described for infections with SARS-CoV-2 which may lead to an increase in …

Introduction: The objective of the present research was to evaluate the possible association
between the N-terminal pro-brain type natriuretic peptide (NT-proBNP) levels and in-hospital …

Pre-existing heart failure (HF) in diagnosed patients with coronavirus disease 2019 (COVID-
19) is associated with a close to two-fold increased mortality rate compared to COVID-19 …

Abstract The coronavirus disease 2019 (COVID-19) took the world by storm after the first
case of COVID-19 emerged in China on December 8, 2019. The disease is generally …

Early diagnosis and treatment of diseases are crucial research areas of human health. For
early diagnosis, one method that has proven efficient is the detection of biomarkers which …

Background and aims Myocardial injury defined by elevation of cardiac troponins (cTn) in
the course of coronavirus disease 2019 (COVID-19) pandemic has been reported, though …

Increased concentrations of B-type natriuretic peptide (BNP), N-terminal pro-B-type
natriuretic peptide (NT-proBNP) and high-sensitivity troponin I (HsTnI) in COVID-19 patients …